MIM
RMTI icon

MetLife Investment Management’s Rockwell Medical RMTI Stock Holding History

MetLife Investment Management’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-235
Closed -$77.9K – 2382
2019
Q2 		$77.9K Hold
235
– – ﹤0.01% 2399
2019
Q1 		$147K Buy
+235
New +$107K ﹤0.01% 2153
2018
Q3 		– Sell
-171
Closed -$93K – 2628
2018
Q2 		$93K Hold
171
– – ﹤0.01% 2164
2018
Q1 		$98K Hold
171
– – ﹤0.01% 2156
2017
Q4 		$110K Buy
+171
New +$120K ﹤0.01% 2186

Other funds holding RMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MetLife Investment Management's RMTI Position: Q3 2019 in Review

MetLife Investment Management sold out of Rockwell Medical (RMTI) in Q3 2019, closing a stake of 235 shares — an estimated $77.9K sold.

MetLife Investment Management first reported a position in RMTI in Q4 2017 and held it in 5 quarters. The position peaked at $147K in Q1 2019. 90 funds tracked by Wall St. Rank hold RMTI as of Q3 2019.

  • MetLife Investment Management reported no remaining Rockwell Medical position as of Q3 2019 after selling out during the quarter.
  • MetLife Investment Management sold 235 Rockwell Medical shares in Q3 2019, an estimated $77.9K.
  • MetLife Investment Management first reported a position in Rockwell Medical in Q4 2017 and held it in 5 quarters.
  • MetLife Investment Management's Rockwell Medical position peaked at $147K in Q1 2019.
  • 90 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2019.

Based on MetLife Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.